Two Sigma Investments’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $198K | Sell |
477,934
-64,721
| -12% | -$26.9K | ﹤0.01% | 2869 |
|
|
2025
Q1 | $338K | Sell |
542,655
-161,476
| -23% | -$101K | ﹤0.01% | 2609 |
|
|
2024
Q4 | $1.18M | Buy |
704,131
+44,072
| +7% | +$73.6K | ﹤0.01% | 2018 |
|
|
2024
Q3 | $1.2M | Buy |
660,059
+367,833
| +126% | +$669K | ﹤0.01% | 1959 |
|
|
2024
Q2 | $1.76M | Buy |
292,226
+226,771
| +346% | +$1.37M | ﹤0.01% | 1565 |
|
|
2024
Q1 | $730K | Sell |
65,455
-466
| -0.7% | -$5.2K | ﹤0.01% | 2080 |
|
|
2023
Q4 | $982K | Buy |
+65,921
| New | +$982K | ﹤0.01% | 2018 |
|
|
2023
Q2 | – | Sell |
-108,351
| Closed | -$490K | – | 2907 |
|
|
2023
Q1 | $490K | Buy |
108,351
+62,351
| +136% | +$282K | ﹤0.01% | 2146 |
|
|
2022
Q4 | $518K | Sell |
46,000
-60,652
| -57% | -$684K | ﹤0.01% | 1944 |
|
|
2022
Q3 | $1.02M | Sell |
106,652
-137,820
| -56% | -$1.32M | ﹤0.01% | 1421 |
|
|
2022
Q2 | $1.98M | Buy |
244,472
+97,377
| +66% | +$788K | 0.01% | 1166 |
|
|
2022
Q1 | $2.49M | Sell |
147,095
-242,107
| -62% | -$4.09M | 0.01% | 1217 |
|
|
2021
Q4 | $8.36M | Buy |
389,202
+386,302
| +13,321% | +$8.3M | 0.02% | 704 |
|
|
2021
Q3 | $214K | Buy |
+2,900
| New | +$214K | ﹤0.01% | 2294 |
|